HOME >> BIOLOGY >> NEWS
Ginkgo herbal supplements vary widely in content

New faster analytical technique could help address quality control issues

Consumers of Ginkgo biloba herbal products, offered in alternative medicine circles as a remedy for just about everything from dementia to impotence, may not be getting their money's worth, according to a new study by scientists at the University of Idaho. Using a new analytical chemistry technique they developed specifically to examine Ginkgo samples, the researchers found variations of up to tenfold in the Ginkgo products they tested.

"Consumers seldom can be sure exactly what they are buying," says chemistry professor Chen Wai, Ph.D., lead researcher for the study, which will appear in the July 15 print issue of the peer-reviewed science journal Analytical Chemistry, published by the American Chemical Society, the world's largest scientific society. The report initially was published on the journal's Web site on May 29.

"The large variation of active ingredients found in Ginkgo biloba products could be a problem for the consumers," the researchers write in the journal article.

Ginkgo products are based on herbal extracts from the leaves of the Ginkgo biloba tree, also known as the maidenhair tree, which first appeared on Earth during the time of the dinosaurs about 200 million years ago. Widely marketed as a way of improving mental alertness and slowing the development of Alzheimer's disease, Ginkgo supplements are among the top selling herbal products in both Europe and the U.S. and have long been a staple of Chinese herbalists.

Chemical substances known as ginkgolides and bilobalide, found in the leaves of the tree, are believed to be the most pharmacologically active compounds, say the researchers. However, they point out, as is the case with many herbal products, the active ingredients are usually present in only trace amounts along with large quantities of other compounds. Determining the amount of ginkgolides and bilobalide in Ginkgo produ
'"/>

Contact: Charmayne Marsh
y_march@acs.org
202-872-4445
American Chemical Society
17-Jun-1999


Page: 1 2

Related biology news :

1. Oncologists evaluate Chinese herbal medicine
2. Chemical found in herbal medicine might complicate pregnancy
3. East meets West: A new memory enhancing drug based on chinese herbal medicine
4. American Ginseng reduces blood sugar: implications for diabetes and herbal research
5. Quality of herbal remedies often is guesswork, expert says
6. Nearly half of all women 65 and older now use herbal products to feel better, but dont tell their doctors
7. Safety of isoflavones in dietary supplements targeted by Illinois initiative
8. Virtual counselor supplements traditional genetic counseling
9. Calcium supplements associated with decreased risk of large bowel polyps
10. Studies show preventive value of food supplements
11. Study says: whey to greater muscle strength is through training and protein supplements

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Ginkgo herbal supplements vary widely content

(Date:2/5/2015)... 2015 Despite a lack of advancements ... as consumer electronics, automotive, storage and telecommunication has ... (SMT) screen printers. Innovations in electronics and conversion ... the adoption curve up. Meanwhile, sale volumes of ... dispensers are indispensable in the production of complex ...
(Date:1/22/2015)... 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics industry ... new website design. "When we launched FindBiometrics 12 ... Peter O,Neill , founder and CEO of FindBiometrics. "Now it,s ... from the key players on a very broad scale.  We ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
Breaking Biology News(10 mins):End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2
(Date:3/3/2015)... , March 3, 2015 Fried, Frank, Harris, ... I.D. Lewis has joined the Firm as a ... the New York office. Mr. ... matters, as well as other intellectual property and general ... Mr. Lewis represents both plaintiffs and defendants in a ...
(Date:3/3/2015)... , March 3, 2015  RegeneRx Biopharmaceuticals, Inc. ... in the scientific journal, Expert Opinion on Biological ... colleague, Dr. Zhenggang Zhang , at the Henry ... reported that Thymosin beta 4 (TB4) has the capacity ... 24 hours or more post-injury, leading to neurological recovery ...
(Date:3/3/2015)... AtheroNova Inc. (OTCQB: AHRO) today announced that the ... under Chapter 11 of the U.S. Bankruptcy Code in the ... , Santa Ana division (the "Bankruptcy ... are expected to be jointly administered. The Company ... sale process, for all or substantially all of its assets ...
(Date:3/3/2015)... Switzerland (PRWEB) March 03, 2015 ... for drug discovery and life science research, today ... Biologics (TM) enterprise platform for use at Pfizer ... and Europe. Genedata is supporting Pfizer’s global deployment ... Technologies (GBT), Centers for Therapeutic Innovation (CTI), and ...
Breaking Biology Technology:Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 2AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 3AtheroNova and its Subsidiary File for Chapter 11 Bankruptcy Protection 4Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3
Cached News: